Neuralert Monitor for Stroke Detection
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial team or your doctor.
What data supports the effectiveness of the Neuralert Monitoring System for stroke detection?
Research on wearable technology in stroke rehabilitation shows that wearable sensors can effectively monitor and encourage arm movement in stroke patients, suggesting that similar technology in the Neuralert Monitoring System could be useful for stroke detection by providing continuous monitoring and timely alerts.12345
How is the Neuralert Monitoring System treatment different from other stroke treatments?
What is the purpose of this trial?
This trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session will consist of wearing a Neuralert device on each arm. For this pilot trial, we are interested in learning about Wi-Fi connectivity, successful data transmission, integration into clinical workflow, usability and tolerability.
Eligibility Criteria
This trial is for individuals who are undergoing surgery and are at risk of stroke. Participants will be monitored using the Neuralert system to detect potential strokes early. The device will be worn on each arm for up to five days, or until battery life ends.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Monitoring
Participants are monitored using the Neuralert device to detect strokes and assess device connectivity, data transmission, and usability.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Neuralert Monitoring System
Neuralert Monitoring System is already approved in United States for the following indications:
- Stroke detection in hospitalized patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
Neuralert Technologies LLC
Lead Sponsor